NT

Nitu Tiwari

Active Director Director DIN 09636164
DIN 09636164 First appointment Jun 2022 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2022
Shareholding value •••• Premium profile

About Nitu Tiwari

Data last updated:

Nitu Tiwari is a Director at Skyline Remedies Private Limited (since 2022). The company operates in Chemicals. Skyline Remedies Private Limited reported revenue of ₹1.4 Lakh (FY 2023).

DIN 09636164
Primary Designation Director
Industry Chemicals
First Appointment 13 Jun 2022
Oldest Company Age 4 yrs
Largest company Skyline Remedies Private Limited · ₹1.4 Lakh (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Skyline Remedies Private Limited U24230BR2022PTC058393
Director13 Jun 20222022₹1.4 Lakh (FY 2023)Active

Board colleagues of Nitu Tiwari

Directorship timeline

Open interactive timeline →
Skyline Remedies Private Limited
Premium access

Shareholding and investment profile for Nitu Tiwari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nitu Tiwari

Nitu Tiwari currently holds 1 directorship: Skyline Remedies Private Limited (Director, since 13 Jun 2022, revenue ₹1.4 Lakh (FY 2023)).

Nitu Tiwari was first appointed on 13 Jun 2022 as Director at Skyline Remedies Private Limited.

The current boards of Nitu Tiwari's companies include Omprakash Upadhyay (Skyline Remedies Private Limited), Sadnand Chaubey (Skyline Remedies Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available